This article provides an overview of cerebrovascular hemodynamics, acute stroke pathophysiology, and collateral circulation, which are pivotal in the modern imaging of ischemic stroke that guides the care of the patient with stroke. Recent Findings: Neuroimaging provides extensive information on the brain and vascular health. Multimodal CT and MRI delineate the hemodynamics of ischemic stroke that may be used to guide treatment decisions and prognosticate regarding expected outcomes. Mismatch imaging with either CT or MRI may identify patients with salvageable regions who are at risk and likely to benefit from reperfusion therapy, even if they are outside the standard time window. Imaging of collateral circulation and determination of collateral grade may predict greater reperfusion, lower hemorrhage risk, and better functional outcome. Current neuroimaging technology also enables the identification of patients at high risk of hemorrhagic transformation or those who may be harmed by treatment or unlikely to benefit from it. Summary: This article reviews the use and impact of imaging for the patient with ischemic stroke, emphasizing how imaging builds upon clinical evaluation to establish diagnosis or etiology, reveal key pathophysiology, and guide therapeutic decisions. FIGURE 2-12 Mismatch profiles. Baseline and follow-up diffusion-weighted imaging (DWI), perfusion-weighted MRI, and magnetic resonance angiography (MRA) scans for patients with different MRI profiles. Arrows point to the occlusion on MRA. Lesion volumes represent the total lesion volume (volumes from each brain slice are summed). The colored scale on the perfusion-weighted MRI maps indicates the degree of delay (in seconds) of gadolinium arrival relative to the arrival of the arterial input. Color within the ventricles on the perfusion-weighted MRI maps is an artifact and is not included in the perfusion-weighted MRI volume. At 30 days, the mismatch profile patient had a modified Rankin Scale score of 2 and National Institutes of Health Stroke Scale score of 2; the malignant profile patient died from intracranial hemorrhage on hospital day 3. MCA = middle cerebral artery; NIHSS = National Institutes of Health Stroke Scale; PWI = perfusion-weighted MRI; tPA = tissue plasminogen activator. Modified with
INTRODUCTION
Advanced imaging technologies have dramatically changed the approach to ischemic stroke management. While the "time is brain" mantra has led to efficient stroke delivery on a system/population level, modern neuroimaging provides rapid profiling of patient-specific tissue viability, vessel status, and cerebral perfusion that have further enhanced treatment decisions and stroke outcomes. 1Y6 Noninvasive multimodal CT and MRI enable prompt diagnosis, identify treatable underlying causes of stroke, enhance selection of candidates for reperfusion therapy within or outside of standard windows, and predict outcomes. Multimodal CT includes CT angiography (CTA) and CT perfusion, whereas multimodal MRI includes parenchymal sequences such as diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) maps, gradient recalled echo (GRE), susceptibilityweighted imaging (SWI), fluid-attenuated inversion recovery (FLAIR), magnetic resonance angiography (MRA), and perfusion-weighted MRI. As stroke is dynamic, any of these single imaging depictions reflects only a snapshot in time in the evolution of infarct growth. Combinations of these modalities and the serial evaluation of disease course provide real-time data to reflect the individual patient course.
No standardized imaging protocols for acute stroke currently exist, other than joint statements from professional societies. 7, 8 Nevertheless, the aim of neuroimaging in acute stroke is to provide rapid information on tissue and vessels to enhance rational decisions for reperfusion therapy without causing harm from delays. Such imaging protocols are therefore dependent on available resources, local experience, and clinician preference. Without proper clinical context or adequate expertise, imaging may be misleading, introduce harm, and waste time and resources, yet imaging often accelerates clinical decision making.
The following sections describe cerebrovascular hemodynamics, acute stroke pathophysiology, and collateral circulation, which are pivotal in the modern imaging of ischemic stroke. Clinical and image-based patient selection for IV thrombosis and intraarterial thrombectomy and prognostication are discussed in conjunction with case scenarios.
PATHOPHYSIOLOGY OF ACUTE ISCHEMIC STROKE
The 3-to 4.5-hour time window for IV thrombolysis following onset of stroke symptoms is derived from population studies 9 that do not account for the marked variations in individual patients' parenchymal or vascular anatomy, pathophysiology, and cerebral reserve, all of which are important factors that influence stroke outcome. Advances in multimodal CT/MRI for stroke are founded on the basis of hemodynamics and account for how such variables enable clinicians to make more individualized (rather than population-based) therapeutic decisions. Key hemodynamic parameters are defined in Table 2-1 . Arterial occlusion, as in ischemic stroke, causes decreased cerebral blood flow and cerebral perfusion pressure. In 1985, Powers and Raichle described three stages of hemodynamic compromise 10 ; Figure 2 -1 11 and Figure 2-2 12 show stage 1 compensatory cerebral autoregulation that maintains constant cerebral blood flow via maximal dilation of small arteries and arterioles and recruitment of collaterals, producing a compensatory increase in cerebral blood volume, thereby offsetting the potential prolongation of time parameters such as mean transit time, time to peak, and time to maximum (Tmax). Mean transit time is defined as the average of the transit time of blood through a given brain region. The transit time of blood through the brain parenchyma varies depending on the distance traveled between arterial inflow and venous outflow and is measured in seconds. Tmax is the time to peak of the residue function, indicating a delay in contrast bolus arrival between the arterial input function and the tissue. A Tmax of 0 reflects normal blood supply in normal tissue without delay. Conversely, a Tmax greater than KEY POINTS h Advanced neuroimaging can provide real-time information on the state of the brain parenchyma and neurovasculature, which may guide treatment outside of current time windows.
h Every image serves to answer specific clinical questions to guide treatment decisions.
h Advances in neuroimaging in stroke are built on the basis of hemodynamics; accounting for these variables allows physicians to make more individualized (rather than population-based) therapeutic decisions. MTT = mean transit time; Tmax = time to maximum; TTP = time to peak. a Cerebral blood volume (CBV) is the total volume of blood in a given unit of brain volume (mL/100 g). Cerebral blood flow (CBF) is the volume of blood moving through a given unit of brain volume per unit time (mL/100 g/min). Mean transit time (MTT) is the average transit time of blood through a given brain region in seconds. The central volume principal is defined as CBF = CBV/MTT. 0 is often associated with an acute ischemic lesion owing to arterial delay. When mean transit time is increased, as in ischemic stroke, red blood cells spend a longer time within oxygenpermeable capillaries; this allows for an increase in oxygen extraction from the capillary network by the brain tissue. In stage II, when maximal autoregulatory vasodilation is exhausted, oxygen extraction fraction (the percent of the oxygen extracted from the blood by tissue during its passage through the capillary network) is increased to maintain brain tissue oxygenation and metabolism necessary for cellular viability. In stage III, when the autoregulatory range of cerebral perfusion pressure reduction is overwhelmed at the ischemic core, it results in a decrease of cerebral blood volume and an ensuing decrease in cerebral blood flow until it crosses the threshold when collaterals fail, with venous collapse leading to tissue oxygenation decrease and, ultimately, bioenergetic cell death. 12 Symptom onset is only an approximation of stroke onset from vessel occlusion. Clinical symptoms are observed below a certain threshold of cerebral blood flow. At very low cerebral blood flow, cerebral infarction occurs within minutes; at higher levels of cerebral blood flow, it may take hours before infarction occurs because tissue viability is dependent on the degree and the duration of cerebral blood flow, as demonstrated in Figure 2 -3. 13, 14 Collateral flow is the intervening factor that determines how long the patient can be asymptomatic before stroke evolves after occlusion. 4 The perfusion-diffusion mismatch model was based on these ischemic stages. Ischemic core refers to areas in which irreversible cell injury has occurred. The ischemic penumbra refers to tissue at risk of infarction if reperfusion does not occur in a timely manner. This dysfunctional but salvageable tissue has been the target of all reperfusion and neuroprotection therapies.
COLLATERAL CIRCULATION HEMODYNAMICS AND ANATOMY
The cerebral collateral circulation exists to protect the brain against ischemia and sustain the penumbra. It is a dynamic system that can preserve cerebral blood flow to the brain when the primary vessels fail. Collateral perfusion varies across individuals and influences the time course of ischemic injury, stroke severity, imaging findings, and therapeutic opportunities. 4, 15 In ischemic stroke, occlusion or stenosis of an arterial segment impairs blood flow to the downstream territory and increases fluid shear stress; mechanical stimulation of the vessel wall causes cytokine release and vascular remodeling to dilate the vessel, leading to recruitment of collaterals. 5, 16 All segments of the cerebral circulation, from arterial inflow routes to the microcirculation and downstream venous channels, are involved KEY POINTS h The ischemic penumbra refers to tissue at risk of infarction if reperfusion does not occur in a timely manner. This dysfunctional but salvageable tissue has been the target of all reperfusion and neuroprotection therapies.
h The cerebral collateral circulation exists to protect the brain against ischemia and sustain the penumbra. progressive decrease in cerebral perfusion pressure and progression through various stages of impaired cerebral circulation. In stage I, cerebral autoregulation enables vascular dilation and collateral recruitments, leading to increased cerebral blood volume (CBV) to maintain cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO 2 ). In stage II, oxygen extraction fraction (OEF) is increased to sustain CMRO 2 with gradual decrease in CBV and collateral failure. In stage III, OEF is exhausted and CMRO 2 has declined, leading to cell death and irreversible infarct. Cerebrovascular reserve (CVR) decreases progressively with hemodynamic failure. in sustaining collateral perfusion, whereas arterial anastomoses provide alternative routes to rapidly shunt flow around an arterial occlusion. 17 Figure 2-4 shows principal sites of compensatory collateral anastomoses: (1) large artery communications between the extracranial and intracranial circulations, (2) completeness of the circle of Willis, and (3) leptomeningeal anastomoses providing cortical surface perfusion. 16 In the setting of acute or chronic occlusions, these connections can supply sufficient blood flow to large portions of the affected territory through shunting and retrograde flow. Nevertheless, regardless of the robustness of collaterals on presentation, collaterals will eventually fail without prompt reperfusion.
CLINICAL INDICATIONS FOR NEUROIMAGING IN ACUTE ISCHEMIC STROKE
When ordering neuroimaging for acute stroke management, key questions to always consider when deciding the optimal imaging to obtain include: (1) Is the stroke ischemic or hemorrhagic? (2) What's the size and location? (3) What's the cause of stroke? (4) Is the patient a candidate for IV tissue from the facial (1), maxillary (2), and middle meningeal (3) arteries to the ophthalmic artery and dural arteriolar anastomoses from the middle meningeal artery (4) and occipital artery through the mastoid foramen (5) and parietal foramen (6) . Intracranial arterial collateral circulation in B, frontal and C, lateral views. Shown are the posterior communicating artery (1), leptomeningeal anastomoses between anterior and middle cerebral arteries (2) and between posterior and middle cerebral arteries (3), the tectal plexus between posterior cerebral and superior cerebellar arteries (4), anastomoses of distal cerebellar arteries (5) , and the anterior communicating artery (6) .
Reprinted with permission from Liebeskind DS, Stroke. 16 B 2003 American Heart Association, Inc. stroke.ahajournals.org/content/34/9/2279.long. plasminogen activator (tPA)? (these could be answered with noncontrast CT or MRI); (5) Is there a large vessel occlusion? (6) Is the patient a candidate for intraarterial thrombectomy? (these could be answered using CTA/ MRA or digital subtraction angiography [DSA]); (7) Is there an ischemic penumbra? (this could be assessed using CT or MR perfusion).
Advantages and disadvantages of various noninvasive neuroimaging modalities for acute stroke evaluation are summarized in Table 2 
PATIENT SELECTION FOR INTRAVENOUS THROMBOLYSIS
A targeted clinical assessment (history, neurologic examination, laboratory values) remains the cornerstone (and initial step) of stroke evaluation and selection for IV tPA. The National Institutes of Health Stroke Scale (NIHSS) score provides important information KEY POINT h Collateral flow in ischemic stroke is a dynamic process and will eventually fail if timely reperfusion is not established. about the severity of stroke and prognosis and influences decisions about acute treatment. Initial stroke imaging can be done using either noncontrast head CT or MRI to differentiate hemorrhagic (15%) from ischemic stroke and determine the size (whether it is more than one-third of the middle cerebral artery [MCA] territory) and location. The choice is based on the available infrastructure and staff, as well as the experience of the stroke team.
Imaging of the Ischemic Core
The ischemic core may be imaged using noncontrast CT and various MRI sequences, including DWI, ADC mapping, and FLAIR.
Computed tomography. Noncontrast CT is the most widely used firstline imaging tool in patients with acute stroke and is recommended as an initial mode of imaging to assist in making decisions for IV tPA. 7 Acquisition of further imaging, such as MRI or CTA, should not delay administration of IV thrombolysis. Early ischemic changes on noncontrast CT appear as hypodensity (cytotoxic edema), loss of gray-white differentiation, cortical swelling, and loss of sulcation (effacement of brain sulcus from tissue swelling). Ischemic changes in the anterior circulation can be quantified topographically with the Alberta Stroke Program Early CT Score (ASPECTS), a simple 10-point pretreatment noncontrast CT score that divides the MCA territory into 10 regions and identifies patients with stroke who are unlikely to have good outcome from thrombolysis (Figure 2-5 18 ). Any ischemic lesion on axial CT cuts at the level of the caudate head or below is adjudicated to a ganglionic ASPECTS region (M1YM3, insula, caudate nucleus, lentiform nucleus, internal capsule); ischemic lesions above the level of the caudate head are adjudicated to a supra-ganglionic ASPECTS region (M4YM6). The caudate nucleus is assessed in both the ganglionic level (head of caudate) and supraganglionic level (body and tail of caudate). To compute the ASPECTS, a single point is subtracted from 10 for evidence of early ischemic change in each of the 10 ASPECTS regions. A score of 10 reflects a normal CT scan; a score of 0 indicates diffuse ischemic involvement throughout the complete MCA territory. 19 Figure 2-6 demonstrates an example of a malignant ischemic infarct (hypodense) of the entire left MCA territory with hemorrhagic conversion (hyperdense), corresponding to poor collaterals on angiography.
The use of noncontrast CT to detect hemorrhage has the advantage of fast acquisition and wide availability ( CT has a specificity of 56% to 100% and poor sensitivity (20% to 75%) for detecting early ischemic changes (within a 6-to 8-hour window), particularly in patients with posterior fossa ischemia. 20 DWI is a better choice of imaging modality to show early ischemic brain injury (within less than 6 hours from onset) with sensitivity of 91% to 100% and specificity of 86% to 100%. 21 Magnetic resonance imaging. In the late 1980s, DWI and time-of-flight MRA were transformative advancements in vascular neurology as they enabled rapid diagnosis of stroke and determination of etiology to allow timely treatment (DWI signals appear within a few minutes after ischemia). 21 When combined in various sequences (DWI/ADC/ FLAIR/GRE), MRI alone captures an enormous amount of information on stroke severity and chronicity. DWI measures the net movement of water in tissue due to molecular motion and shows hyperintense ischemic tissue changes within minutes to a few hours after arterial occlusion due to a reduction of the ADC. The ADC reduction occurs primarily in the intracellular space associated with disruption of membrane ionic homeostasis and cytotoxic edema.
In terms of clinical interpretation, an increased signal on DWI (described as hyperintense) followed by a decreased ADC map represents irreversible ischemia, ie, an infarcted brain region; the combination of DWI and ADC maps with T2-weighted images allows acute lesions to be distinguished from subacute or older acute ischemic stroke lesions. When a lesion is hyperintense on both DWI and the ADC map and hypointense on the exponential image, the phenomenon is referred to as T2 shine-through, which may be seen with late subacute infarcts or chronic ischemic lesions.
The extent (size) and pattern of the DWI lesion are important therapeutic and prognostic biomarkers. Patients with a smaller diffusion core (70 mL or less) treated with IV/intraarterial thrombolysis have a significantly better outcome than patients with a larger core. 22 The pattern of DWI lesion helps to identify stroke etiology. For example, an isolated lenticulostriate lesion points to lacunar infarct. Multiple lesions in different vascular territories suggest a cardioembolic/aortoembolic source, whereas scattered lesions in one vascular territory are associated with large artery atherosclerosis as demonstrated in Figure 2-7 .
Comparing the signal intensities on DWI, ADC, and FLAIR images can help distinguish acute, subacute, and chronic stroke ( Figure 2-8 23 ). Positive signals on DWI without corresponding FLAIR hyperintensity imply that the stroke occurred less than 4.5 hours before imaging (sensitivity of 62%, specificity of 78%). 24 ADC values are reduced in the first 7 to 10 days, then pseudonormalize (the period in the evaluation of stroke when ADC is normal), and finally increase. 25 Figure 2 -8 shows serial imaging across four time points, demonstrating the DWI, ADC, and FLAIR temporal signal changes. Given the temporal relationship of MRI sequences, concurrent viewing of MRI sequences may help select patients with an unclear "last known well time" or wake-up stroke for acute reperfusion treatment as demonstrated in Case 2-1.
MRI is also helpful to rule out intracranial hemorrhage and predict hemorrhagic transformation. GRE/SWI is more sensitive than CT for the detection of chronic hemorrhage, particularly chronic microbleeds. 27 The extent of microbleeds is a biomarker of the severity of the underlying vascular disease and is associated with an increased risk of spontaneous intracranial hemorrhage. 28 Vascular signs on parenchymal imaging. While noncontrast CT and MRI are paramount in imaging brain parenchyma, a number of clinically relevant vascular signs indicate vessel patency or suggestions of thrombus. For example, the hyperdense MCA sign on noncontrast CT and blooming artifact on GRE MRI (Figure 2-10 29 ) may indicate red cellYpredominant occlusive thrombus, which may or may not be associated with a poor outcome. 29 FLAIR sequences may show vascular hyperintensities due to slow retrograde flow in the leptomeningeal vessels feeding the cortex (Figure 2-11 ) 30 ; these findings may be an important clue to the presence of a proximal arterial occlusion and good retrograde collateral flow, which is a favorable prognostic indicator associated with smaller ischemic lesion volume on MRI and milder clinical severity. 31 Furthermore, high ASPECTS on noncontrast CT in a known MCA occlusion may be seen as a marker of robust collateral flow. 32 . Noncontrast CT appears normal. Regions of ADC appear pseudonormal on the subacute scan, increasing by 1 month (arrows). DWI appears hyperintense across all time points. FLAIR lesion volume appears largest at 2.4 days as a result of edema before stabilizing its infarct size at 42 days.
Reprinted with permission from Wu O, et al, Neuroimag Clin N Am. 23 B 2011 Elsevier, Inc. www.sciencedirect.com/ science/article/pii/S1052514911000220.
Case 2-1
A 71-year-old woman woke up with mild aphasia and right hemiparesis, with a National Institutes of Health Stroke Scale score of 7. Noncontrast CT showed old lacunes, but no hemorrhage. Diffusion-weighted images and apparent diffusion coefficient map showed subtle new left centrum semiovale diffusion changes without corresponding fluid-attenuated inversion recovery (FLAIR) signals (Figure 2-9 26 ). Vessel imaging with time-of-flight magnetic resonance angiography (MRA) showed occlusion of the left middle cerebral artery (Figure 2-9 ). Perfusion maps showed relatively preserved cerebral blood flow and cerebral blood volume but marked prolongation of transit times (mean transit time and time to maximum [Tmax]), suggesting a target mismatch pattern (Figure 2-9) . Given the large mismatch pattern and proximal M1 occlusion, the patient underwent intraarterial thrombectomy and achieved thrombolysis in cerebral infarction (TICI) 2b status reperfusion (near-complete to complete recanalization). She recovered rapidly postprocedurally with a modified Rankin Scale score of 1 at 2-year follow-up.
Continued on page 1409
marginal changes or no change (high ASPECTS). 32 
Imaging of Penumbral Tissue and Diffusion-Perfusion Mismatch
Perfusion imaging gives a snapshot of stroke pathophysiology. It estimates the relative volumes of penumbral regions that may be salvaged with timely reperfusion therapy and of infarcted core that cannot be salvaged and conveys a higher risk of hemorrhagic transformation. 33 DWI/ perfusion-weighted MRI and CT perfusion are imaging modalities commonly used to rapidly identify patients with stroke with persistent penumbra thought to be optimal candidates for reperfusion therapies. 7 Table 2 -1 defines key perfusion-diffusion parameters and their trends. While no standardized perfusion parameter currently exists, a Tmax longer than 6 seconds is a commonly used threshold Comment. Multimodal CT/MRI can help identify a favorable target mismatch profile in patients with an unclear last known well time (eg, wake-up stroke) and help make the decision to extend acute reperfusion treatment beyond the standard window of 3 to 4.5 hours.
Case modified with permission from Rowley HA, Stroke. 26 Continued from page 1408 that identifies ischemic tissue that is likely to be irreversibly injured if reperfusion does not occur. 34 A mismatch is considered significant if the penumbra is at least 20% of the ischemic core volume. 34 In general, both the presence of a penumbra and reversal of a penumbra correlate with improved clinical outcomes.
The target mismatch profile (small DWI lesion volume, large perfusionweighted MRI lesion volume) and the malignant profile (large DWI lesion volume, large perfusion-weighted MRI lesion volume), as defined by the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study, are key patterns to look for when reviewing perfusion imaging to identify optimal candidates for later thrombolysis without causing additional harm. 35 Target mismatch is associated with good outcome; a malignant mismatch profile is associated with severe intracranial hemorrhage and poor outcome after reperfusion. 35 Figure 2-12 shows important mismatch patterns.
PATIENT SELECTION FOR INTRAARTERIAL THROMBECTOMY
Clinically, after the question of whether hemorrhage exists has been established and tPA has been administered,
KEY POINT
h Diffusion-weighted imaging/perfusionweighted MRI and CT perfusion are imaging modalities commonly used to rapidly identify patients with stroke with persistent penumbra thought to be optimal candidates for reperfusion therapies. 40 ) includes recommendations of patients who should receive endovascular interventions: those who are 18 years of age or older; have a baseline modified Rankin Scale score of 1 or less, an NIHSS score of 6 or more, internal carotid artery or M1 occlusion and received tPA, and an ASPECTS of 6 or higher; and start treatment within 6 hours of symptom onset (Class I; Level of Evidence A). 8 Furthermore, those who had contraindications to IV thrombolysis, such as those on anticoagulation, or who showed no improvement after tPA or early clinical deterioration after tPA from early recurrence of stroke should be considered for intraarterial thrombectomy.
Many comprehensive stroke centers with streamlined endovascular expertise consider endovascular therapy up to 12 hours after onset of symptoms for anterior circulation stroke and up to 24 Key exclusion criteria commonly used in prior endovascular trials were rapidly improving NIHSS score of less than 4, glucose lower than 50 mg/dL or higher than 400 mg/dL, systolic blood pressure higher than 185 mm Hg, diastolic blood pressure higher than 110 mm Hg, international normalized ratio (INR) higher than 3, platelet count less than 50,000 cells/6L, intracranial hemorrhage, or ischemic stroke within the past 3 months.
Society joint statements recommend three major vascular imaging strategies 7 : (1) noncontrast CT with CTA with or without CT perfusion, (2) noncontrast CT with DSA, and (3) MRI (DWI, FLAIR, GRE/SWI with or without perfusion-weighted MRI and arterial spin labeling) with or without MRA. Of the three options, noncontrast CT with CTA with or without CT perfusion from aortic arch to vertex is a favored strategy for selecting intraarterial thrombectomy candidates as CT is fast and widely available. 41 
Imaging of Occlusion
Identification of an occluded large vessel provides additional therapeutic and prognostic information. Various noninvasive vascular imaging KEY POINT h A malignant mismatch profile is associated with severe intracranial hemorrhage and poor outcome after reperfusion.
modalities are compared in Table 2-2. CTA is the most widely used noninvasive test for identifying major intracranial vessel occlusion with 98.4% sensitivity, 98.1% specificity, and 98.2% accuracy, with high interobserver reliability for large vessel occlusions when compared with DSA. 42, 43 CT-based techniques provide a more accessible and expedient assessment for grading collateral flow in the acute setting than conventional angiography. In particular, when combined with CT perfusion, CTA can rapidly generate quantitative and qualitative parameters that enable discrimination between normal tissue, penumbra, and infarcted core. 44 However, CTA and CT perfusion are limited by radiation and contrast. Time-offlight MRA is another widely used noninvasive vessel imaging technique without radiation or contrast (sensitivity 84% to 87%, specificity 85% to 98%). 43 It is limited by flow artifact, which may result in overestimation of vessel stenosis, and motion artifacts as some patients with stroke may not be able to follow commands.
Imaging of Collaterals
In the absence of recanalization, collateral blood flow is the determinant of penumbral survival. Good collaterals are associated with greater reperfusion, better median NIHSS score at day 7, and better modified Rankin Scale score at day 90. Conversely, poor collaterals are associated with symptomatic hemorrhage. 45Y47 The gold standard of imaging of collateral circulation is conventional DSA because of the complex configuration and often diminutive caliber of collateral vessels. However, its applicability is limited by its invasive nature, relatively long acquisition and procedural times, and low accessibility; thus, it is not practical as the first-line imaging study for general use. 48 While many collateral grading scales exist, the most commonly used is the one proposed by the American Society of Interventional and Therapeutic Neuroradiology (ASITN) and the Society of Interventional Radiology (SIR). The ASITN/SIR collateral grading system is a 5-point scale (0 = worst, 4 = best). The grades are defined and corresponding angiographic findings described in Figure 2-13 . 49 Many noninvasive ways to image collaterals exist. 17 Traditional static CTA and MRA are limited in their ability to assess collateral flow as the image attainment is delayed, with relatively low flow leading to underestimation of collateral quality. Multiphase CTA and arterial spin labeling MRA are newer dynamic imaging acquisitions that allow dynamic assessments of flow comparable to conventional DSA. 47, 50 Multiphase CTA has been tested for its clinical utility in the ESCAPE study with good interrater reliability. 37, 51 Furthermore, with noncontrast CT, a low ASPECTS correlates with low collateral grades, as described in the Solitaire With the Intention for Thrombectomy (SWIFT) 46 and Interventional Management of Stroke III (IMSIII) trials. 4, 45 FLAIR sequences reveal slow reverse collateral flow in arterial segments beyond an occlusion, which is a reliable marker for the presence of collateral flow (Figure 2-11) . 30 Recanalization and reperfusion clearly influence stroke outcome. 36Y40 Thrombolysis in cerebral infarction (TICI) is a commonly used angiographic score for revascularization/reperfusion in neurointervention for acute ischemic stroke. 49 Figure 2-14 52 describes the angiographic findings of TICI scores. Case 2-2 demonstrates image-based patient selection for intraarterial thrombectomy and outcomes. TICI 0 shows no recanalization/reperfusion of the primary occluded vessel (arrow). TICI 1 shows partial reperfusion beyond the initial occlusion but no filling of distal middle cerebral artery branches. TICI 2a and TICI 2b correspond to partial (less than 50%) and near-complete (more than 50% but less than full) reperfusion beyond the occlusion site, respectively. TICI 3 indicates complete reperfusion of the entire middle cerebral artery territory. 
COMPARISON OF IMAGE-BASED SELECTION CRITERIA IN RECENT ENDOVASCULAR TRIALS
In 2014Y2015, five randomized clinical trials (MR CLEAN, 36 ESCAPE, 37 EXTEND-IA, 38 SWIFT PRIME, 39 and REVASCAT 40 ) using various image-based selection criteria building on prior trials and clinical experience showed benefit of endovascular treatment of stroke when patients were carefully selected and treated in a timely manner. Details of these trials are listed in Table 2 Spain; 2012Y2014 N = 206 8 hours ASPECTS = Alberta Stroke Program Early CT Score; CT = computed tomography; CTA = computed tomography angiography; DSA = digital subtraction angiography; DWI = diffusion-weighted imaging; MR = magnetic resonance; MRA = magnetic resonance angiography; NCT = noncontrast computed tomography; rCBF = relative cerebral blood flow; TICI = thrombolysis in cerebral infarction (score); Tmax = time to maximum. a Imaging entry criteria were revised midway through the study. After imaging entry criteria revision, sites could enroll based on ASPECTS findings only but were still encouraged to obtain perfusion imaging and use this information if available. A total of 71 patients were enrolled under the initial imaging entry criteria and 125 patients under the revised imaging entry criteria.
were the confirmation of a proximal occlusion (mostly with CTA) and use of a newer generation of stent retriever. Four of the trials (all except for MR CLEAN) used imaging to exclude patients with a large ischemic core or poor collateral grades. 41 The trials with the highest odds of good functional outcome used CT/magnetic resonance (MR) perfusion to select patients with both a small core in farct and large penumbral tissue (EXTEND-IA, SWIFT PRIME) or the presence of moderate to good collateral circulation (ESCAPE were the choice of imaging modalities and ischemic-penumbral thresholds. Multiphase CTA and ASPECTS were used to exclude patients with poor collaterals and large ischemic core in ESCAPE. CT/MR perfusion and an automated postprocessing protocol with a priori thresholds to determine ischemic core and penumbra were used in EXTEND-IA and SWIFT PRIME. However, debate remains over the precise CT perfusion thresholds for patient selection. 53 Clearly, standardized perfusion methods and thresholds are needed to reliably determine the core and penumbra to facilitate clinical use and dissemination of these techniques.
IMAGING OF POST-REPERFUSION MANAGEMENT
Post-reperfusion therapy care is essential because approximately 25% of patients may have neurologic worsening during the first 24 to 48 hours after stroke and it is difficult to predict which patients will deteriorate. 54 A dedicated stroke unit with nursing expertise is pivotal in the management of patients with acute stroke. Key components of medical therapy for acute stroke beyond thrombolysis include blood pressure modulation, antiplatelet and statins, cardiac monitoring, respiratory support, normothermia, and normoglycemia. 8, 54 The dynamic nature of ischemic stroke and response to reperfusion can be captured by serial multimodal CT/MRI, comparing the change in ischemic lesion patterns from baseline over ensuing days and weeks. Clinical response to reperfusion can sometimes be difficult to capture. Early neurologic deterioration maybe due to tPA failure, recurrent stroke, or hemorrhagic transformation. Conversely, rapidly improved symptoms may not be from successful recanalization but rather due to improved cerebral perfusion from head-down positioning despite persisting proximal arterial occlusion. Use of advanced imaging for early diagnosis and treatment of acute ischemic stroke also facilitates prognostication, rehabilitation planning, and early secondary stroke prevention.
IMAGING OF MINOR STROKE AND TRANSIENT ISCHEMIC ATTACK
The ABCD 2 (age, blood pressure, clinical features, duration, presence of diabetes mellitus) clinical risk prediction score is commonly used to triage patients with suspected transient ischemic attack (TIA) for hospital admission (threshold at 4 or higher) versus outpatient follow-up within 7 days; however, studies have called into question its ability to reliably stratify patients at high risk for stroke. 55 A meta-analysis involving 13,766 TIA admissions revealed that ABCD 2 score did not reliably determine those at low versus high risk of early recurrent stroke: 20% of patients with an ABCD 2 score of less than 4 had more than 50% carotid stenosis or atrial fibrillation, and 35% to 41% of TIA mimics had an ABCD 2 score of 4 or more. 55 Perhaps incorporating an imaging screen, such as perfusion imaging, may improve its predictive power. Furthermore, patients with rapidly improving symptoms or who have low NIHSS scores often are excluded from acute reperfusion therapy; however, almost one-third of cases will go on to sustain substantial disability. 56 Perfusion imaging (perfusion-weighted MRI or CT perfusion) can identify this subgroup of patients with high-risk minor strokes or unstable TIA who are likely to decline because of asymptomatic vascular stenosis who may benefit from higher-intensity treatment. 57 Case 2-3 demonstrates the utility of multimodal MR for unstable TIA.
Case 2-3
An 82-year-old man with hypertension presented with two episodes of aphasia, each lasting 30 minutes. His initial National Institutes of Health Stroke Scale (NIHSS) score was 0, and his ABCD 2 score was 4. Diffusion-weighted imaging (DWI) showed no evidence of acute infarction (Figure 2-16A 58 ) ; perfusion-weighted MRI showed hypoperfusion on the time-to-peak map (Figure 2-16B ) in the entire left middle cerebral artery territory (arrows). On hospital day 2, he was noted to have sudden-onset right hemiplegia and aphasia, with an NIHSS score of 18, as observed by his neurointensive care unit nurse, with clear time of onset at 6:00 AM. His head position was flattened, and he was given 2 L of 0.9% normal saline with improved symptoms to an NIHSS score of 12. He was given IV tissue plasminogen activator and underwent intraarterial thrombectomy with marked clinical improvement and a postprocedural NIHSS score of 0. He was discharged home with dual antiplatelet therapy, atorvastatin, and amlodipine.
Comment. This patient's clinical symptoms were consistent with transient ischemic attack. DWI has limited sensitivity (90%) for very small infarcts, particularly in the brainstem. In addition, a short episode of ischemia that is not severe enough to cause permanent tissue injury may cause symptoms in the absence of lesions detected by DWI. The combined use of DWI and perfusion-weighted MRI may improve the sensitivity for detection of tissue ischemia and, more important, ''tissue at risk'' penumbra that calls for prompt workup of the transient ischemic attack to offer patients appropriate intensity of treatment as in this patient. The diagnostic utility of perfusion-weighted MRI remains to be confirmed in large prospective studies.
Case modified with permission from Sorensen AG, Ay H, Neuroimaging Clin N Am. 58 B 2011 Elsevier. www.sciencedirect.com/science/article/pii/S1052514911000141. 
CONCLUSION
Neuroimaging provides extensive information on the brain and vascular health. Every image serves to answer specific clinical questions that enhance treatment decisions, building upon the clinical evaluation. Factors such as patient age, premorbid status, the patient's wishes and expectations of good outcome, and time from onset remain important. Use of advanced neuroimaging technologies in routine care of the patient with ischemic stroke will accelerate translational research in the field, train a new generation of clinical neuroimagers, and, most important, optimize patient outcomes. With recent overwhelming evidence supporting image-based patient selection for acute reperfusion therapy to optimize stroke outcome and avoid harm, a need for standardization and automation of perfusion imaging parameters to facilitate dissemination of the technology clearly exists.
